Rights and permissions
About this article
Cite this article
TETRAHYDROCANNABINOL: WHAT VALUE AS AN ANTIEMETIC IN CANCER PATIENTS?. Inpharma Wkly. 291, 15–16 (1981). https://doi.org/10.1007/BF03312659
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03312659